Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests.

Article Details

Citation

Xue F, Yu H, Maurer LH, Memoli VA, Nutile-McMenemy N, Schuster MK, Bowden DW, Mao J, Noll WW

Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests.

Hum Mol Genet. 1994 Apr;3(4):635-8.

PubMed ID
7915165 [ View in PubMed
]
Abstract

Multiple endocrine neoplasia type 2A (MEN 2A) and familial medullary thyroid carcinoma (FMTC) are two closely related cancer syndromes inherited in an autosomal dominant manner. Mutations in the RET proto-oncogene were found in MEN 2A and FMTC families. In this study we report seven different germline mutations in the RET proto-oncogene in five of five MEN 2A and five of six FMTC families. Each of the mutations involves a cysteine residue in the extracellular cysteine-rich domain of the RET receptor tyrosine kinase. We developed simple polymerase chain reaction based diagnostic tests for all seven mutations in these families.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Proto-oncogene tyrosine-protein kinase receptor RetP07949Details